|
|
|
Insider
Information: |
Scangos George A |
Relationship: |
Director |
City: |
South San Francisco |
State: |
CA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
5 |
|
Direct
Shares |
942,251 |
|
Indirect Shares
|
3,765,803 |
|
|
Direct
Value |
$30,703,107 |
|
|
Indirect Value
|
$5,340,307 |
|
|
Total
Shares |
4,708,054 |
|
|
Total
Value |
$36,043,415 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Exelixis Inc |
EXEL |
Director |
2020-05-18 |
714,717 |
2020-05-18 |
23,595 |
Premium* |
|
Anadys Pharmaceuticals Inc |
ANDS |
Director |
2008-08-26 |
33,188 |
2004-03-31 |
0 |
Premium* |
|
Biogen Idec Inc |
BIIB |
Chief Executive Office... |
2016-07-21 |
54,779 |
2016-07-21 |
10,756 |
Premium* |
|
Agilent Technologies Inc |
A |
Director |
2024-05-29 |
18,578 |
2024-05-29 |
17,893 |
Premium* |
|
Vir Biotechnology, Inc. |
VIR |
Director |
2024-05-30 |
120,989 |
2024-05-30 |
3,713,559 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
379 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 12 of 16
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
EXEL |
Exelixis Inc |
Director |
|
2019-05-02 |
4 |
AS |
$20.00 |
$300,000 |
D/D |
(15,000) |
1,233,031 |
0 |
- |
|
EXEL |
Exelixis Inc |
Director |
|
2019-06-04 |
4 |
AS |
$20.00 |
$300,000 |
D/D |
(15,000) |
1,208,031 |
0 |
- |
|
EXEL |
Exelixis Inc |
Director |
|
2020-02-12 |
4 |
AS |
$20.02 |
$420,420 |
D/D |
(21,000) |
1,013,031 |
0 |
% |
|
EXEL |
Exelixis Inc |
Director |
|
2020-02-11 |
4 |
AS |
$20.14 |
$80,560 |
D/D |
(4,000) |
1,034,031 |
0 |
% |
|
EXEL |
Exelixis Inc |
Director |
|
2020-01-15 |
4 |
AS |
$20.39 |
$509,750 |
D/D |
(25,000) |
1,063,031 |
0 |
% |
|
EXEL |
Exelixis Inc |
Director |
|
2019-08-01 |
4 |
AS |
$20.48 |
$823,738 |
D/D |
(40,000) |
1,128,031 |
0 |
- |
|
EXEL |
Exelixis Inc |
Director |
|
2020-02-18 |
4 |
AS |
$20.73 |
$1,036,500 |
D/D |
(50,000) |
963,031 |
0 |
% |
|
EXEL |
Exelixis Inc |
Director |
|
2018-12-03 |
4 |
AS |
$21.16 |
$846,400 |
D/D |
(40,000) |
1,456,981 |
0 |
- |
|
EXEL |
Exelixis Inc |
Director |
|
2019-07-01 |
4 |
AS |
$21.58 |
$863,200 |
D/D |
(40,000) |
1,168,031 |
0 |
- |
|
EXEL |
Exelixis Inc |
Director |
|
2019-03-01 |
4 |
AS |
$22.66 |
$906,400 |
D/D |
(40,000) |
1,323,031 |
0 |
- |
|
VIR |
Vir Biotechnology, Inc. |
President and CEO |
|
2023-02-24 |
4 |
AS |
$22.74 |
$352,682 |
D/D |
(15,119) |
168,489 |
0 |
- |
|
EXEL |
Exelixis Inc |
Director |
|
2020-04-20 |
4 |
AS |
$23.39 |
$1,194,637 |
D/D |
(50,000) |
863,031 |
0 |
% |
|
EXEL |
Exelixis Inc |
Director |
|
2019-02-01 |
4 |
AS |
$23.53 |
$941,200 |
D/D |
(40,000) |
1,363,031 |
0 |
- |
|
EXEL |
Exelixis Inc |
Director |
|
2019-04-01 |
4 |
AS |
$24.02 |
$960,800 |
D/D |
(40,000) |
1,278,031 |
0 |
- |
|
EXEL |
Exelixis Inc |
Director |
|
2019-03-14 |
4 |
AS |
$25.00 |
$125,000 |
D/D |
(5,000) |
1,318,031 |
0 |
- |
|
EXEL |
Exelixis Inc |
Director |
|
2019-04-03 |
4 |
AS |
$25.03 |
$125,150 |
D/D |
(5,000) |
1,273,031 |
0 |
- |
|
EXEL |
Exelixis Inc |
Director |
|
2020-04-21 |
4 |
AS |
$25.04 |
$145,232 |
D/D |
(5,800) |
857,231 |
0 |
% |
|
EXEL |
Exelixis Inc |
Director |
|
2020-04-22 |
4 |
AS |
$25.05 |
$105,210 |
D/D |
(4,200) |
853,031 |
0 |
% |
|
VIR |
Vir Biotechnology, Inc. |
President and CEO |
|
2023-02-17 |
4 |
AS |
$25.29 |
$250,199 |
D/D |
(9,894) |
214,095 |
0 |
- |
|
EXEL |
Exelixis Inc |
Director |
|
2020-04-23 |
4 |
AS |
$25.68 |
$2,598,635 |
D/D |
(100,000) |
753,031 |
0 |
% |
|
EXEL |
Exelixis Inc |
Director |
|
2020-05-18 |
4 |
AS |
$25.96 |
$1,947,000 |
D/D |
(75,000) |
714,717 |
0 |
% |
|
VIR |
Vir Biotechnology, Inc. |
President and CEO |
|
2023-02-23 |
4 |
AS |
$25.97 |
$328,065 |
D/D |
(12,631) |
183,608 |
0 |
- |
|
EXEL |
Exelixis Inc |
Director |
|
2020-04-24 |
4 |
AS |
$26.24 |
$393,600 |
D/D |
(15,000) |
738,031 |
0 |
% |
|
VIR |
Vir Biotechnology, Inc. |
President and CEO |
|
2023-02-21 |
4 |
AS |
$28.02 |
$505,318 |
D/D |
(17,856) |
196,239 |
0 |
- |
|
VIR |
Vir Biotechnology, Inc. |
President and CEO |
|
2020-04-14 |
4 |
D |
$29.56 |
$6,999,985 |
I/I |
(236,806) |
1,907,329 |
0 |
- |
|
379 Records found
|
|
Page 12 of 16 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|